Opinions were raised that it would be difficult for candidates under development as new drugs for hypertension, such as Baxdrostat, Aprocitentan, and Firibastat, to replace existing drugs. It is expected that it will fill the unmet demand rather than take the place of the prescribed treatment.

Professor Woong-Gil Choi of Chungbuk National University Hospital held a hypertension drug treatment update session at the '2023 Korean Society of Hypertension Spring Conference' held at COEX in Daegu on the 20th and said, "Major hypertension drug candidates are existing drugs rather than replacing drugs already prescribed in clinical settings. It will be a drug that can help the unfilled part.” The reason why th